Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel antidiabetic agents disclosed in recent patent literature

Jan. 30, 2007

Somavert approved for acromegaly in Japan

Jan. 30, 2007

Januvia recommended for approval in E.U.

Jan. 30, 2007

Ajinomoto licenses antidiabetic agent to Boehringer Ingelheim

Jan. 30, 2007

Preclinical profile of GW-590735 described at GSK

Jan. 30, 2007

Novel PPAR alpha agonist profiled at PRD enters the clinic

Jan. 29, 2007

GEM OS1 Bone Graft shows efficacy in healing distal radius fractures

Jan. 29, 2007

New phase II trial studies OBE-101 for weight loss in obese patients

Jan. 26, 2007

Novel nonpeptide GLP-1 receptor agonist exhibits antidiabetic efficacy in vivo

Jan. 26, 2007

GlaxoSmithKline reports on melanocortin 4 receptor agonists as novel antiobesity compounds

Jan. 26, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...